Ecthyma gangrenosum in pediatric patients: 10-year experience at the National Institute of Pediatrics.
Journal
International journal of dermatology
ISSN: 1365-4632
Titre abrégé: Int J Dermatol
Pays: England
ID NLM: 0243704
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
revised:
09
08
2023
received:
20
04
2023
accepted:
30
08
2023
pubmed:
13
9
2023
medline:
13
9
2023
entrez:
13
9
2023
Statut:
ppublish
Résumé
Ecthyma gangrenosum (EG) usually results from the hematogenous seeding of the skin in the setting of bacteremia, mostly by Pseudomonas aeruginosa, especially in immunocompromised patients. It presents as erythematous-violaceous macules, or plaques with surrounding erythema before rapidly progressing to bullae and necrotic-ulcerative eschars. We performed a retrospective chart review of EG patients diagnosed at the National Institute of Pediatrics. Data included demographics, underlying disease, cutaneous lesions, location, evolution, microbiologic, histopathologic findings, and treatment. Data were analyzed by descriptive statistics; Mann-Whitney U test and Fisher's exact test were used to evaluate differences between groups. Seventeen patients with a mean age of 12.5 (6-16) years were included. The most common underlying disease was acute lymphoblastic leukemia (59%), three patients were not immunocompromised (17%). A total of 18 episodes of EG were recorded, 10 (55%) were disseminated at presentation. Systemic manifestations included fever (100%), pain (88.9%), asthenia and adynamia (22.2%). P. aeruginosa was isolated in 10 (55%) cases, followed by Staphylococcus aureus in four. Three patients had sepsis at onset (17%). A comparison between localized versus disseminated, pseudomonal versus nonpseudomonal, and bacteremic versus nonbacteremic EG was performed with no statistical difference between any of the groups, except for longer treatment time for pseudomonal EG, and longer hospitalization days for both pseudomonal EG and bacteremia. Fever and pain in the setting of rapidly evolving necrotic lesions should prompt the clinical suspicion of EG and the installment of empiric treatment pending culture results.
Sections du résumé
BACKGROUND
BACKGROUND
Ecthyma gangrenosum (EG) usually results from the hematogenous seeding of the skin in the setting of bacteremia, mostly by Pseudomonas aeruginosa, especially in immunocompromised patients. It presents as erythematous-violaceous macules, or plaques with surrounding erythema before rapidly progressing to bullae and necrotic-ulcerative eschars.
METHODS
METHODS
We performed a retrospective chart review of EG patients diagnosed at the National Institute of Pediatrics. Data included demographics, underlying disease, cutaneous lesions, location, evolution, microbiologic, histopathologic findings, and treatment. Data were analyzed by descriptive statistics; Mann-Whitney U test and Fisher's exact test were used to evaluate differences between groups.
RESULTS
RESULTS
Seventeen patients with a mean age of 12.5 (6-16) years were included. The most common underlying disease was acute lymphoblastic leukemia (59%), three patients were not immunocompromised (17%). A total of 18 episodes of EG were recorded, 10 (55%) were disseminated at presentation. Systemic manifestations included fever (100%), pain (88.9%), asthenia and adynamia (22.2%). P. aeruginosa was isolated in 10 (55%) cases, followed by Staphylococcus aureus in four. Three patients had sepsis at onset (17%). A comparison between localized versus disseminated, pseudomonal versus nonpseudomonal, and bacteremic versus nonbacteremic EG was performed with no statistical difference between any of the groups, except for longer treatment time for pseudomonal EG, and longer hospitalization days for both pseudomonal EG and bacteremia.
CONCLUSIONS
CONCLUSIONS
Fever and pain in the setting of rapidly evolving necrotic lesions should prompt the clinical suspicion of EG and the installment of empiric treatment pending culture results.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1359-1364Informations de copyright
© 2023 the International Society of Dermatology.
Références
Vaiman M, Lazarovitch T, Heller L, Lotan G. Ecthyma gangrenosum and ecthyma-like lesions: review article. Eur J Clin Microbiol Infect Dis. 2015;34(4):633-639. https://doi.org/10.1007/s10096-014-2277-6
Zomorrodi A, Wald ER. Ecthyma gangrenosum: considerations in a previously healthy child. Pediatr Infect Dis J. 2002;21(12):1161-1164. https://doi.org/10.1097/00006454-200212000-00016
Bozkurt I, Yuksel EP, Sunbul M. Ecthyma gangrenosum in a previously healthy patient. Indian Dermatol Online J. 2015;6(5):336-338. https://doi.org/10.4103/2229-5178.164479
Reich HL, Williams Fadeyi D, Naik NS, Honig PJ, Yan AC. Non-pseudomonal ecthyma gangrenosum. J Am Acad Dermatol. 2004;50(5 Suppl):S114-S117. https://doi.org/10.1016/j.jaad.2003.09.019
Birlutiu V, Birlutiu RM, Baicu M, Iancu GM. A case report of double etiology of ecthyma gangrenosum: Pseudomonas aeruginosa and Enterococcus faecalis in an immunocompromised child occurred during influenza evolution. Medicine (Baltimore). 2019;98(20):e15651. https://doi.org/10.1097/MD.0000000000015651
Jaque A, Moll-Manzur C, Dossi MT, Berroeta-Mauriziano D, Araos-Baeriswyl E, Monsalve X. Ectima gangrenoso secundario a Staphylococcus aureus [Ecthyma gangrenosum caused by Staphylococcus aureus]. Rev Chilena Infectol. 2016;33(3):336-339. https://doi.org/10.4067/S0716-10182016000300015
Tanaka A, Yanagi T, Seo T, Mai S, Miyazawa H, Ujiie H. Ecthyma gangrenosum caused by Streptococcus pyogenes: report of a case and review of the literature. J Dermatol. 2022;49(8):e266-e267. https://doi.org/10.1111/1346-8138.16396
Altwegg M, Geiss HK. Aeromonas as a human pathogen. Crit Rev Microbiol. 1989;16(4):253-286. https://doi.org/10.3109/10408418909105478
Son YM, Na SY, Lee HY, Baek JO, Lee JR, Roh JY. Ecthyma gangrenosum: a rare cutaneous manifestation caused by Stenotrophomonas maltophilia in a leukemic patient. Ann Dermatol. 2009;21(4):389-392. https://doi.org/10.5021/ad.2009.21.4.389
Gałązka P, Kaczor P, Kałużny K, Leis K. Ecthyma gangrenosum as a serious complication of Pseudomonas aeruginosa infection in departments of paediatric oncology. Postepy Dermatol Alergol. 2021;38(4):537-543. https://doi.org/10.5114/ada.2020.100747
Wuyts L, Wojciechowski M, Maes P, Matthieu L, Lambert J, Aerts O. Juvenile ecthyma gangrenosum caused by Pseudomonas aeruginosa revealing an underlying neutropenia: case report and review of the literature. J Eur Acad Dermatol Venereol. 2019;33(4):781-785. https://doi.org/10.1111/jdv.15420
Spernovasilis N, Psichogiou M, Poulakou G. Skin manifestations of Pseudomonas aeruginosa infections. Curr Opin Infect Dis. 2021;34(2):72-79. https://doi.org/10.1097/QCO.0000000000000717
Shah M, Crane JS. Ecthyma gangrenosum. StatPearls. Treasure Island, FL: StatPearls Publishing; 2022.
Hitschman F, Kreilich K. Zur pathogenese des bacillus pyocyaneus und zur aetiologie des ekthyma gangraenosum. Wien Klin Wochenschr. 1897;10:1093-1101.
Guerrero-González GA, Ocampo-Candiani J. Ecthyma gangrenosum: a report of eight cases. An Bras Dermatol. 2017;92(5):698-700. https://doi.org/10.1590/abd1806-4841.20175580
Muggeo P, Zama D, Decembrino N, Onofrillo D, Frenos S, Colombini A, et al. Ecthyma gangrenosum in children with cancer: diagnosis at a glance. A retrospective study from the infection working group of Italian Pediatric Hematology Oncology Association. Pediatr Infect Dis J. 2022;41(3):238-242. https://doi.org/10.1097/INF.0000000000003377
Cohen N, Capua T, Bilavsky E, Dias-Polak H, Levin D, Grisaru-Soen G. Ecthyma gangrenosum skin lesions in previously healthy children. Acta Paediatr. 2015;104(3):e134-e138. https://doi.org/10.1111/apa.12889
Vaiman M, Lasarovitch T, Heller L, Lotan G. Ecthyma gangrenosum versus ecthyma-like lesions: should we separate these conditions? Acta Dermatovenerol Alp Pannonica Adriat. 2015;24(4):69-72. https://doi.org/10.15570/actaapa.2015.18
Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol. 2017;18(6):719-731. https://doi.org/10.1016/S1470-2045(17)30186-9
World Health Organization. CureAll framework: WHO global initiative for childhood cancer: increasing access, advancing quality, saving lives. Geneva: World Health Organization; 2021. https://apps.who.int/iris/handle/10665/347370
Gao W, Howden BP, Stinear TP. Evolution of virulence in Enterococcus faecium, a hospital-adapted opportunistic pathogen. Curr Opin Microbiol. 2018;41:76-82. https://doi.org/10.1016/j.mib.2017.11.030
Eltwisy HO, Twisy HO, Hafez MH, Sayed IM, El-Mokhtar MA. Clinical infections, antibiotic resistance, and pathogenesis of Staphylococcus haemolyticus. Microorganisms. 2022;10(6):1130. https://doi.org/10.3390/microorganisms10061130
Willems RJ, van Schaik W. Transition of Enterococcus faecium from commensal organism to nosocomial pathogen. Future Microbiol. 2009;4(9):1125-1135. https://doi.org/10.2217/fmb.09.82
Dhawan B, Gadepalli R, Kapil A. In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India. Diagn Microbiol Infect Dis. 2009;65(2):196-198. https://doi.org/10.1016/j.diagmicrobio.2009.05.015
Wade JJ. Enterococcus faecium in hospitals. Eur J Clin Microbiol Infect Dis. 1997;16(2):113-119. https://doi.org/10.1007/BF01709469
Reich HL, Fadeyi DW, Naik NS, Honig PJ, Yan AC. Nonpseudomonal ecthyma gangrenosum. J Am Acad Dermatol. 2004;50(5 Suppl):S114-S117.
el Baze P, Thyss A, Vinti H, Deville A, Dellamonica P, Ortonne JP. A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia. Acta Derm Venereol. 1991;71(5):411-415.
Huminer D, Siegman-Igra Y, Morduchowicz G, Pitlik SD. Ecthyma gangrenosum without bacteremia. Report of six cases and review of the literature. Arch Intern Med. 1987;147:299-301. https://doi.org/10.1001/archinte.147.2.299
Empinotti JC, Uyeda H, Ruaro RT, Galhardo AP, Bonatto DC. Pyodermitis. An Bras Dermatol. 2012;87(2):277-284. https://doi.org/10.1590/s0365-05962012000200013
Molgó MN, Arriagada CE, Salomone CB, Vera CK, Giesen LF, Solar AG, et al. Skin necrosis: report of eleven cases. Rev Med Chil. 2014;142(1):118-124. https://doi.org/10.4067/S0034-98872014000100019